The Health and National Security Risks of Drug Shortages

Andrew G. Shuman, MD, FACS, HEC-C

Associate Professor in the Department of Otolaryngology - Head and Neck Surgery Chief of the Clinical Ethics Service in the Center for the Bioethics and Social Sciences in Medicine (CBSSM)

Dr. Shuman is a cancer surgeon and bioethicist at the University of Michigan and the VA Ann Arbor Health System. He is internationally recognized as a thought leader in ethical issues arising within the field of surgical oncology. His greatest impact involves applying his perspective as a practicing surgeon and clinical ethicist to bioethics research. He has a portfolio of publications in leading journals in the fields of ethics, oncology and otolaryngology including The New England Journal of Medicine and JAMA.

On Wednesday, March 22, 2023, Dr. Shuman testified before the Senate Homeland Security and Governmental Affairs Committee at a hearing, titled "Drug Shortage Health and National Security Risks: Underlying Causes and Needed Reforms". During his testimony, Shuman discussed his experiences dealing with drug shortages in his work and how they affected his patients, explaining the complex decisions physicians and other medical professionals face when confronted with drug shortages.